about
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label studyElectroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?A benefit-risk assessment of agomelatine in the treatment of major depression.The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.Effects of typhoid vaccine on inflammation and sleep in healthy participants: a double-blind, placebo-controlled, crossover study.Does melatonin treatment change emotional processing? Implications for understanding the antidepressant mechanism of agomelatine.
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Does agomelatine block 5-HT2C receptors in humans?
@en
Does agomelatine block 5-HT2C receptors in humans?
@nl
type
label
Does agomelatine block 5-HT2C receptors in humans?
@en
Does agomelatine block 5-HT2C receptors in humans?
@nl
prefLabel
Does agomelatine block 5-HT2C receptors in humans?
@en
Does agomelatine block 5-HT2C receptors in humans?
@nl
P2093
P2860
P1433
P1476
Does agomelatine block 5-HT2C receptors in humans?
@en
P2093
Nancy B Rawlings
Sarah F B McTavish
Susannah Brain
P2860
P2888
P304
P356
10.1007/S00213-010-1993-6
P577
2010-08-21T00:00:00Z